Literature DB >> 1974311

The effect of plasma valine, isoleucine and leucine on the control of the flux through tyrosine- and tryptophan-hydroxylase in the brain.

F A Hommes1, J S Lee.   

Abstract

The effect of increasing blood levels of valine, isoleucine and leucine on the fluxes through tyrosine and tryptophan hydroxylase in brain has been calculated and analysed in terms of flux control coefficients. It is concluded that any beneficial effect of increasing the concentration of these amino acids in phenylketonuria patients is not due to a decrease in brain phenylalanine or an improved neurotransmitter synthesis through tyrosine or tryptophan hydroxylase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974311     DOI: 10.1007/bf01799677

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  4 in total

1.  The control of 5-hydroxytryptamine and dopamine synthesis in the brain: a theoretical approach.

Authors:  F A Hommes; J S Lee
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 2.  The role of the blood-brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninaemia.

Authors:  F A Hommes
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 3.  Brain metabolism: a perspective from the blood-brain barrier.

Authors:  W M Pardridge
Journal:  Physiol Rev       Date:  1983-10       Impact factor: 37.312

4.  Preliminary support for the oral administration of valine, isoleucine and leucine for phenylketonuria.

Authors:  M K Jordan; R L Brunner; M M Hunt; H K Berry
Journal:  Dev Med Child Neurol       Date:  1985-02       Impact factor: 5.449

  4 in total
  2 in total

1.  Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria.

Authors:  G M Knudsen; S Hasselbalch; P B Toft; E Christensen; O B Paulson; H Lou
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

2.  Analysis of the saliva metabolic signature in patients with primary Sjögren's syndrome.

Authors:  Zhen Li; Yue Mu; Chunlan Guo; Xin You; Xiaoyan Liu; Qian Li; Wei Sun
Journal:  PLoS One       Date:  2022-06-02       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.